Emami soars 7% as board to consider share buyback on March 24

Meanwhile, in the past three months, the stock has shed 16 per cent, as against 4 per cent decline in the S&P BSE Sensex.

SI Reporter Mumbai
emami, fmcg

According to the company, owing to the pandemic, there is a strong demand for healthcare and hygiene products.

Shares of Emami were up 7 per cent at Rs 369.45 on the BSE in Wednesday’s intra-day trade after the personal care company announced a buyback plan.
The board of directors of the company is scheduled to meet on Friday, March 24, 2023 to consider a proposal for buyback of fully paid-up equity shares of the company, Emami said in an exchange filing.
The primary objective of a share buyback programme is to arrest the fall in the value of a stock by reducing the supply of the stock, which essentially pushes up the share price through a better price to earnings (P/E) multiple.

Also Read

Emami net profit up 7.8% at Rs 237.13 cr, says rural demand slowing

What is a share buyback?

Infosys shares drop 2.6% despite buyback proposal, end at Rs 1,425

Emami Sept quarter net flat at Rs 184 crore, pre-tax profit dips 18%

IEX falls 2% as board approves Rs 98 crore share buyback via open market

Hindustan Zinc surges 5% on announcing liberal interim dividend

Stock Market Live: Sensex off day's high, up 150pts; Nifty above 17,150

Stocks to Watch: Tata Motors, IOC, Hind Zinc, Sonata Software, Bandhan Bank

Powered by US boutique investment firm GQG, FPIs turn net buyers

Benchmark indices rebound on global trends, buying in Reliance Industries

Shares of Emami had hit a 52-week low of Rs 340.95 on Monday, March 20, 2023. Meanwhile, in the past three months, the stock was down 16 per cent, as against 4 per cent decline in the S&P BSE Sensex. Further, in past six months, it has slipped 30 per cent, as compared to 1.5 per cent fall in the benchmark index.
Emami is one of India’s leading fast moving consumer goods (FMCG) Companies engaged in manufacturing & marketing of personal care & healthcare products.
Volume growth continued to remain a cause for concern for Emami although the base is likely to turn favourable going forward, according to analysts.
Slowdown in rural areas, where Emami has a higher presence (~55 per cent rural mix) vis-a-vis some of the other FMCG peers, has affected topline performance in the near term even as rural penetration continues to progress steadily with Project Khoj. Rural recovery and correction in Pain Management & Healthcare coming into the base should improve growth going forward. Margins are also expected to improve as pressure from input cost inflation moderates, analysts at Nirmal Bang Institutional Equities said in December quarter result update.


  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 5Y
  • MAX

First Published: Mar 22 2023 | 10:08 AM IST

Explore News